0001203311-22-000057.txt : 20221019
0001203311-22-000057.hdr.sgml : 20221019
20221019191732
ACCESSION NUMBER: 0001203311-22-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221017
FILED AS OF DATE: 20221019
DATE AS OF CHANGE: 20221019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSEY ROGER D
CENTRAL INDEX KEY: 0001741836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 221319500
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-10-17
0
0001060736
Seagen Inc.
SGEN
0001741836
DANSEY ROGER D
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Interim CEO & CMO
Common Stock
2022-10-17
4
M
0
4607
77.45
A
102146
D
Common Stock
2022-10-17
4
S
0
4607
135.0
D
97539
D
Common Stock
2022-10-17
4
M
0
3189
76.86
A
100728
D
Common Stock
2022-10-17
4
S
0
3189
135.0
D
97539
D
Common Stock
2022-10-17
4
M
0
2204
65.11
A
99743
D
Common Stock
2022-10-17
4
S
0
2204
135.0
D
97539
D
Non-Qualified Stock Option (right to buy)
65.11
2022-10-17
4
M
0
2204
0.0
D
2028-06-15
Common Stock
2204
0
D
Non-Qualified Stock Option (right to buy)
76.86
2022-10-17
4
M
0
3189
0.0
D
2028-08-30
Common Stock
3189
0
D
Non-Qualified Stock Option (right to buy)
77.45
2022-10-17
4
M
0
4607
0.0
D
2028-09-07
Common Stock
4607
9403
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Options vested at a rate of 25% on 5/21/2019 and monthly thereafter until all the options were fully vested on 5/21/22.
Options vested at a rate of 25% on 8/30/2019 and monthly thereafter until all the options were fully vested on 8/30/22.
By: /s/ Jennifer Prosba For: Roger Dansey
2022-10-19